BLS-HA101
N/A
Report date: 2022/12/17 16:53:02
NME
Base Information
Drug NameBLS-HA101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBioleaders CorporationCHA Bio & Diostech Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCHA Bio & Diostech Co LtdBioleaders Corporation
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A